Latest Clinical News

FDA Accepts NDA for Gefapixant for Chronic Cough

16 hours ago

The application, submitted by Merck, is based on data from 2 clinical trials evaluating patients with refractory or unexplained chronic cough.

What Is Needed to Improve Pediatric Asthma Controller Therapy Adherence

February 28, 2021

From better education, to remote monitoring and consistent check-ins, clinicians may need to initiate better adherence in their younger, severely ill patients.

Diverse Eosinophilic Esophagitis Symptoms and Care Teams

February 28, 2021

How dupilumab is observed to benefit EoE patients—and who may administer the biologic therapy.

Tezepelumab Benefits Severe, Uncontrolled Asthma in Phase 3 NAVIGATOR Findings

February 28, 2021

An interview on the TSLP inhibitor's effect on exacerbations, hospitalizations, and disease progress over 52-week findings.

Revised Anaphylaxis Diagnostic Guidelines Seen as an Improvement

February 28, 2021

In data presented during AAAAI 21, researchers compared the 2006 and 216 versions of the diagnostic criteria proposed by the NIAD/FAAN.

x